Results from the national "Urgent Conversations" survey, announced today by Eli Lilly and Company (NYSE: LLY), found that ...
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last year, Lilly hopes to introduce Omvoh as its ...
Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven ...
Greece does not have a problem with overtourism, but only faces an issue of excessive concentration of tourists in some areas, Prime Minister Kyriakos Mitsotakis said on Tuesday. Speaking at a Tuesday ...